Back to Search
LESTER LIPTON, M.D.
M.D.
Specialist
NPI: 1083626022Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours.
PMID 18971935·Br J Cancer·2008
3-trial
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.
PMID 18753146·Hum Mol Genet·2008
8-other
Biallelic PMS2 mutations and a distinctive childhood cancer syndrome.
PMID 18376293·J Pediatr Hematol Oncol·2008
5-case
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.
PMID 18372905·Nat Genet·2008
8-other
Cytosine methylation profiling of cancer cell lines.
PMID 18353987·Proc Natl Acad Sci U S A·2008
8-other
Management of MUTYH-associated neoplasia in Australia.
PMID 18298557·Intern Med J·2008
4-observational
Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
PMID 17916174·Intern Med J·2008
4-observational
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
PMID 19088021·Clin Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 51 E 90TH ST
NEW YORK, NY 10128 - Phone
- (212) 427-2429
Quick Facts
- NPI
- 1083626022
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile